Shade Ronnie D, Ross Jennifer A, Van Bockstaele Elisabeth J
Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States.
Department of Pharmacology and Physiology, College of Medicine, Drexel University, Philadelphia, PA, United States.
Front Aging Neurosci. 2022 Oct 4;14:949361. doi: 10.3389/fnagi.2022.949361. eCollection 2022.
is a progressive neurodegenerative disorder characterized histologically in postmortem human brains by the presence of dense protein accumulations known as amyloid plaques and tau tangles. Plaques and tangles develop over decades of aberrant protein processing, post-translational modification, and misfolding throughout an individual's lifetime. We present a foundation of evidence from the literature that suggests chronic stress is associated with increased disease severity in Alzheimer's patient populations. Taken together with preclinical evidence that chronic stress signaling can precipitate cellular distress, we argue that chronic psychological stress renders select circuits more vulnerable to amyloid- and tau- related abnormalities. We discuss the ongoing investigation of systemic and cellular processes that maintain the integrity of protein homeostasis in health and in degenerative conditions such as Alzheimer's disease that have revealed multiple potential therapeutic avenues. For example, the endogenous cannabinoid system traverses the central and peripheral neural systems while simultaneously exerting anti-inflammatory influence over the immune response in the brain and throughout the body. Moreover, the cannabinoid system converges on several stress-integrative neuronal circuits and critical regions of the hypothalamic-pituitary-adrenal axis, with the capacity to dampen responses to psychological and cellular stress. Targeting the cannabinoid system by influencing endogenous processes or exogenously stimulating cannabinoid receptors with natural or synthetic cannabis compounds has been identified as a promising route for Alzheimer's Disease intervention. We build on our foundational framework focusing on the significance of chronic psychological and cellular stress on the development of Alzheimer's neuropathology by integrating literature on cannabinoid function and dysfunction within Alzheimer's Disease and conclude with remarks on optimal strategies for treatment potential.
是一种进行性神经退行性疾病,在死后人类大脑中的组织学特征是存在被称为淀粉样斑块和tau缠结的致密蛋白质聚集物。斑块和缠结在个体一生中数十年的异常蛋白质加工、翻译后修饰和错误折叠过程中形成。我们展示了来自文献的证据基础,表明慢性应激与阿尔茨海默病患者群体中疾病严重程度的增加有关。结合临床前证据表明慢性应激信号可引发细胞应激,我们认为慢性心理应激使特定神经回路更容易受到与淀粉样蛋白和tau相关异常的影响。我们讨论了正在进行的关于维持健康和诸如阿尔茨海默病等退行性疾病中蛋白质稳态完整性的全身和细胞过程的研究,这些研究揭示了多种潜在的治疗途径。例如,内源性大麻素系统贯穿中枢和外周神经系统,同时对大脑和全身的免疫反应发挥抗炎作用。此外,大麻素系统汇聚于几个应激整合神经回路和下丘脑 - 垂体 - 肾上腺轴的关键区域,具有减弱对心理和细胞应激反应的能力。通过影响内源性过程或用天然或合成大麻化合物外源性刺激大麻素受体来靶向大麻素系统已被确定为阿尔茨海默病干预的一条有前景的途径。我们基于我们的基础框架,通过整合关于阿尔茨海默病中大麻素功能和功能障碍的文献,关注慢性心理和细胞应激对阿尔茨海默病神经病理学发展的重要性,并以关于治疗潜力的最佳策略的评论作为结尾。